Vol.

No.

June 18, 2021Jun 18, 2021

DOWNLOAD THE PDF

Cover Story

ARPA-H would launch 1,000 drugs, Eric Lander promises NIH advisors

By Matthew Bin Han Ong

The Advanced Research Projects Agency for Health, the centerpiece of the Biden Administration’s war on disease, is designed to be something much more than an ordinary federal bureaucracy.

NCI Director's Report

Biden’s budget request for NCI would set back Sharpless’s goal of raising R01 paylines to 15%

By Alexandria Carolan

Clinical Trials & Tribulations

Annals of Unintended Consequences: How FDA regulations undermine the biosimilar marketplace and the BPCIA

By Howard S. Hochster and Michael P. Kane

Free In the Archives

On the shoulders of giants: Research milestones and the Rabson-Kirschstein photo archive

Editorial Free

The Cancer Letter receives 8 journalism, design awards

By Paul Goldberg

In Brief

Suresh S. Ramalingam named executive director of Winship Cancer Institute

John V. Cox receives ASCO’s 2021 Joseph V. Simone Award

Conquer Cancer names 2021 ASCO annual meeting Merit Award recipients

Conquer Cancer honors rising oncology professionals

Jazz Pharmaceuticals collaborates with lung cancer groups on digital hub for emotional, social and physical needs of SCLC community

ACCC launches Cancer Buzz TV

Funding Opportunities

DoD Kidney Cancer Research Program funding opportunities for FY21

Thermo Fisher Scientific opens submissions for the Oncomine Clinical Research Grant program

Clinical Roundup

PanCAN adds FibroGen’s drug as treatment arm to adaptive Precision Promise trial

Three studies reinforce efficacy of Venclexta combinations in CLL and AML

Yale Cancer Center study reveals new pathway for brain tumor therapy

Astronomy meets pathology to identify predictive biomarkers for cancer immunotherapy

“Bad fat” suppresses killer T cells from attacking cancer

Drugs & Targets

FDA approves Ayvakit for advanced systemic mastocytosis

PREVIOUS ISSUE

NEXT ISSUE